ANI PHARMACEUTICALS INC·4

Mar 20, 4:07 PM ET

PRZYBYL ARTHUR 4

4 · ANI PHARMACEUTICALS INC · Filed Mar 20, 2019

Insider Transaction Report

Form 4
Period: 2018-03-18
PRZYBYL ARTHUR
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2019-03-18$63.53/sh24,802$1,575,671205,076 total
  • Exercise/Conversion

    Stock Options

    2019-03-189,05238,448 total
    Exercise: $49.51Exp: 2027-03-30Common Stock (9,052 underlying)
  • Sale

    Common Stock

    2019-03-19$63.51/sh2,823$179,289205,076 total
  • Exercise/Conversion

    Stock Options

    2019-03-186,3750 total
    Exercise: $33.00Exp: 2024-03-31Common Stock (6,375 underlying)
  • Exercise/Conversion

    Stock Options

    2019-03-189,37518,750 total
    Exercise: $40.59Exp: 2026-04-06Common Stock (9,375 underlying)
  • Exercise/Conversion

    Stock Options

    2019-03-192,82335,625 total
    Exercise: $49.51Exp: 2027-03-30Common Stock (2,823 underlying)
Footnotes (5)
  • [F1]The shares were sold in multiple trades at prices ranging from $63.49 to $64.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person owns 205,076 shares of the Issuer's common stock following the transaction, which is the same number of shares reported on his most recent prior filing.
  • [F2]The shares were sold in multiple trades at prices ranging from $63.49 to $63.60. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person owns 205,076 shares of the Issuer's common stock following the transaction, which is the same number of shares reported on his most recent prior filing.
  • [F3]Option vests and are exercisable over a four year period beginning on the first anniversary of April 1, 2014.
  • [F4]Option vests and are exercisable over a four year period beginning on the first anniversary of April 7, 2016.
  • [F5]Option vests and are exercisable over a four year period beginning on the first anniversary of March 31, 2017.

Documents

1 file
  • 4
    tv516671_form4.xmlPrimary

    FORM 4